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Molecular ruler mechanism and interfacial catalysis 
of the integral membrane acyltransferase PatA
Itxaso Anso1,2†, Luis G. M. Basso3,4†, Lei Wang5, Alberto Marina1, Edgar D. Páez-Pérez1,6, 
Christian Jäger7, Floriane Gavotto7, Montse Tersa1, Sebastián Perrone1,2,7,  
F.-Xabier Contreras8,9,10, Jacques Prandi11, Martine Gilleron11, Carole L. Linster7, 
Francisco Corzana12, Todd L. Lowary5,13,14, Beatriz Trastoy1,2*, Marcelo E. Guerin1,2,10*
Glycolipids are prominent components of bacterial membranes that play critical roles not only in maintaining the 
structural integrity of the cell but also in modulating host-pathogen interactions. PatA is an essential acyltransferase 
involved in the biosynthesis of phosphatidyl-myo-inositol mannosides (PIMs), key structural elements and viru-
lence factors of Mycobacterium tuberculosis. We demonstrate by electron spin resonance spectroscopy and surface 
plasmon resonance that PatA is an integral membrane acyltransferase tightly anchored to anionic lipid bilayers, 
using a two-helix structural motif and electrostatic interactions. PatA dictates the acyl chain composition of the 
glycolipid by using an acyl chain selectivity “ruler.” We established this by a combination of structural biology, 
enzymatic activity, and binding measurements on chemically synthesized nonhydrolyzable acyl–coenzyme A 
(CoA) derivatives. We propose an interfacial catalytic mechanism that allows PatA to acylate hydrophobic PIMs 
anchored in the inner membrane of mycobacteria, through the use of water-soluble acyl-CoA donors.
INTRODUCTION
Bacterial membranes play fundamental roles not only in the physi-
ology of the cell but also in host–pathogen interactions (1, 2). They 
are primarily used as physiochemical barriers allowing bacterial cells 
to be functionally constituted and differentiated from the environ-
ment (3). Phospholipids and glycolipids are the fundamental building 
blocks, whereas proteins, the other major components of bacterial 
membranes, associate permanently or temporarily with them, per-
forming a diverse set of key functions in the cells (4, 5). Specifically, 
they regulate the selective transport of molecules across the bacterial 
membranes and, as enzymes, they catalyze a myriad of biochemical 
reactions. The bacterial membrane constituents are represented 
by a substantial number of species, the amount and distribution of 
which also varies in space and time (6–12). Therefore, the structural 
diversity of membranes provides identity to bacterial cells, which 
strongly influence the development and maintenance of a large num-
ber of bacteria life forms.
Acyltransferases are enzymes that catalyze the transfer of fatty 
acid chains from activated fatty acid donors to a variety of acceptor 
molecules of different chemical structure and complexity, playing 
key roles in the biosynthesis of phospholipids and glycolipids (4). 
The fatty acid chains can be activated by esterification of their car-
boxyl groups with the thiol group of coenzyme A (CoA) or that of the 
acyl carrier protein (ACP), yielding acyl-thioesters. Acyltransferases, 
as many other enzymes, are very often required to access both hydro-
phobic and hydrophilic substrates that reside within distinct chem-
ical environments defined by the phospholipid/glycolipid-based 
membrane and the aqueous cytoplasm and periplasm, respectively 
(5, 6). The molecular and mechanistic aspects by which membrane 
enzymes, including acyltransferases, govern substrate recognition 
and catalysis represent a major challenge and are, compared to their 
soluble counterparts, poorly understood.
PatA is an essential acyltransferase involved in the biosynthesis 
of phosphatidyl-myo-inositol mannosides (PIMs) and the meta-
bolically related lipomannan (LM) and lipoarabinomannan (LAM). 
These species are glycolipids/lipoglycans noncovalently anchored 
through their phosphatidyl-myo-inositol (PI) moiety to the inner 
and outer membranes of the mycobacterial cell envelope (2, 7–14). 
PIMs, LM, and LAM are thought to be important virulence factors 
during of Mycobacterium tuberculosis infection (15). The PIM fam-
ily of glycolipids is composed of PI mono-, di-, tri-, tetra-, penta-, 
and hexamannosides with different degrees of acylation (7, 8). PIM2 
and PIM6 are the two most abundant classes found in Mycobacterium 
bovis bacillus Calmette-Guérin (BCG), M. tuberculosis H37Rv, and 
Mycobacterium smegmatis 607 (Fig. 1A) (16). According to the 
currently accepted model, the PIM biosynthetic pathway takes place 
on both sides of the mycobacterial inner membrane (IM) (8, 17). 
The early steps occur in the cytosolic face of the IM and involve 
the consecutive action of three enzymes. The phosphatidyl- myo-
inositol mannosyltransferase PimA (Rv2610c in M. tuberculosis 
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H37Rv), which catalyzes the transfer of Manp residue from guano-
sine diphosphate–mannose to the 2-position of the myo-inositol ring 
of PI, to form phosphatidyl-myo-inositol monomannoside (PIM1; 
Fig. 1A) (7, 18–20). PimA was found essential for M. smegmatis 
mc2155 and M. tuberculosis growth in vitro and in vivo (18, 21). The 
second mannosylation step involves the action of another essential 
enzyme PimB (Rv2188c in M. tuberculosis H37Rv), which transfers 
a Manp residue to the 6-position of the myo-inositol ring of PIM1 to 
form PIM2 (20, 22). The PIM acyltransferase A, PatA (Rv2611c in 
M. tuberculosis H37Rv), catalyzes the transfer of a palmitoyl moiety 
from palmitoyl-CoA to the 6-position of the mannose ring linked 
to the 2-position of inositol in PIM1 or PIM2, to obtain Ac1PIM1 or 
Ac1PIM2 (Fig. 1B) (20, 23). PatA was found important for the optimal 
growth of M. smegmatis mc2155 and an essential enzyme for the 
growth of M. tuberculosis in vitro and in vivo (11, 23). Two models 
were originally proposed for the biosynthesis of Ac1PIM2 in myco-
bacteria. In the first model, PI is mannosylated to form PIM1. PIM1 is 
then mannosylated to form PIM2, which is acylated to form Ac1PIM2. 
In the second model, PIM1 is first acylated to Ac1PIM1 and then 
mannosylated to Ac1PIM2. Recent evidence indicates that although 
both pathways might coexist in mycobacteria, the sequence of events 
PI-PIM1-PIM2-Ac1PIM2 is favored (Fig. 1, A and B) (20). Last, Ac1PIM2 
can be further acylated on position 3 of the myo-inositol ring to form 
Ac2PIM2. However, this acyltransferase and most of the mannosyl-
transferases that catalyze the formation of higher PIMs still remains 
to be identified (Fig. 1A) (7).
Fig. 1. Proposed PIM biosynthetic pathway in mycobacteria. (A) The PIM biosynthetic pathway in mycobacteria. According to the currently accepted model, the 
mannosylation steps of the PIM derivatives start in the cytosolic face of the IM with the consecutive mannosylation of PI, catalyzed by PimA and PimB to form PIM2. PIMs 
are further acylated by PatA and by a not yet identified acyltransferase, to form Ac1PIM2 and Ac2PIM2, at the cytosolic face of the IM, respectively. It is worth noting that 
the inner leaflet of the inner mycobacterial membrane is likely composed nearly entirely of Ac2PIM2 (79). Although Ac1PIM2/Ac2PIM2 and Ac1PIM6/Ac2PIM6 are the most 
abundant forms of PIMs in M. bovis BCG, M. tuberculosis H37Rv, and M. smegmatis 607, all forms of PIM2 could eventually translocate to the outer leaflet of the IM by an 
unknown mechanism, which could involve the action of a flippase. PimE (Rv1159), an integral membrane glycosyltransferase family C (GT-C) enzyme that use polyprenyl-linked 
sugars as donors, is involved in the biosynthesis of higher-order PIMs in the periplasmic phase of the IM (17). Other mannosyltransferases involved in the biosynthesis 
of polar PIMs remain to be identified. (B) Specifically, PatA catalyzes the transfer of a palmitoyl moiety from palmitoyl-CoA to the 6-position of the mannose ring linked 
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A close interaction of the enzyme with the cytosolic face of the 
mycobacterial plasma membrane might be a strict requirement for 
PIM1 or PIM2 modification by PatA. Supporting this notion, PatA was 
found to colocalize in mycobacterial membrane fractions (20, 23, 24). 
PatA is the paradigm of a large family of acyltransferases that work 
at the membrane-water interface and for which the understanding 
of the molecular mechanism of substrate recognition and membrane 
association still remains a challenge. Here, surface plasmon resonance 
(SPR), electron spin resonance (ESR), circular dichroism (CD), dif-
ferential scanning calorimetry (DSC), and structural and molecular 
dynamics (MD) data are used to define the membrane association 
mechanism of PatA from M. smegmatis. Moreover, chemical synthesis, 
enzymatic activity, isothermal titration calorimetry (ITC), and x-ray 
crystallography are used to describe the molecular ruler mechanism of 
PatA. Together, our results support a model of interfacial catalysis, 
allowing PatA to recognize both hydrophobic and hydrophilic sub-
strate molecules, that facilitates its reaction at the membrane surface.
RESULTS
PatA preferentially binds to anionic phospholipids
SPR is a powerful technique to study the mechanisms of mem-
brane protein association and integration (25–27). To determine 
whether PatA binds to anionic [1,2-dioleoyl-sn-glycero-3-phospho- 
(1′-rac-glycerol) (DOPG)] or zwitterionic [1,2-dioleoyl-sn-glycero- 
3-phosphocholine (DOPC)] phospholipids, we immobilized small 
unilamellar vesicles (SUVs) composed of DOPG:DOPC (60:40, w/w) 
(DOPG-SUVs) or DOPC (DOPC-SUVs) into a L1 chip and injected 
different concentrations (micromolar range) of purified full-length 
PatA (figs. S1 and S2) to determine the apparent dissociation con-
stants (KD) (see Materials and Methods for details). It is worth not-
ing that the SPR experiments with DOPG-SUVs and DOPC-SUVs 
were performed at 25°C, temperature at which these lipids are in the 
fluid phase (phase transition temperature for DOPG and DOPC are 
−18° and − 17°C, respectively). PatA did not bind to DOPC-SUVs 
(fig. S2B); however, the enzyme showed binding to the anionic DOPG- 
SUVs. Thus, we decided to use the zwitterionic DOPC-SUVs as the 
negative control. As depicted in Fig. 2A, PatA binding to anionic 
DOPG-SUVs is consistent with the strict requirement that a nega-
tive charge needs to be present in the phospholipid for interaction 
with PatA to occur. It is worth noting that it was not possible to mea-
sure the KD value for PatA, because the equilibrium was not reached 
during the injection phase. However, as PatA is injected, the SPR 
signal increases and when the protein injection is stopped, the SPR 
signal remains constant, indicating that the protein is firmly associ-
ated with the DOPG-SUVs (Fig. 2A). We determined that PimB, the 
enzyme that carries out the second step of the PIM biosynthetic path-
way (20), also preferentially binds anionic DOPG-SUVs. However, 
in contrast to PatA, once the injection of PimB is stopped, the SPR 
signal decreased suggesting that the interaction with the lipid bilayer 
is temporarily (Fig. 2B and fig. S2A), typical of peripheral mem-
brane proteins (28). It was possible to measure the binding affinity 
of PimB for DOPG-SUVs (KD), which is in the low micromolar range 
(0.309 ± 0.03 M). We also determined the binding of PatA and 
PimB to 1,2-dimyristoyl-sn-glycero-3-phospho-(1′-rac-glycerol) 
(DMPG):1,2-dimyristoyl-sn-glycero-phosphatidylcholine (DMPC) 
(60:40, w/w) (DMPG-SUVs) or DMPC-SUVs at 30°C, temperature 
at which these lipids are also in the fluid phase (the phase transition 
temperature for DMPG and DMPC are 23° and 24°C, respectively; 
Fig. 2, C and D). DMPG, an anionic saturated phospholipid, is one of 
the most widely used lipid system mimicking bacterial membranes. 
PatA and PimB showed a similar binding interaction with DMPG- 
SUVs than DOPG-SUVs (Fig. 2, C and D). Specifically, PatA remains 
bound to the DMPG-SUVs after stopping the injection while PimB 
dissociates rapidly after the injection ends (Fig. 2, C and D). To fur-
ther explore the differences between PatA and PimB in an environ-
ment more similar to its natural one, we analyzed the binding of both 
enzymes using SUVs generated with membrane lipids isolated from 
M. smegmatis mc2155 cells (Fig. 2, E and F; see Materials and Methods). 
The behavior of the two enzymes was reminiscent of that observed 
with the DOPG-SUVs; however, the association rates were faster for 
both enzymes, and the dissociation rate was faster for PimB, while 
that for PatA did not change. Together, the SPR data indicate that 
(i) PatA and PimB preferentially bind anionic phospholipids and 
(ii) PatA firmly associates with the lipid bilayer, while (iii) PimB as-
sociates temporarily with the lipid bilayer.
We also investigated the interaction between PatA and mem-
branes by CD and DSC (25, 29, 30). CD spectroscopy was used to 
examine the effect of phospholipids binding to the secondary struc-
ture and thermal stability of PatA and PimB. Because both proteins 
preferentially associate with anionic membranes, we analyzed protein 
conformational changes in the presence of DOPG-SUVs and the 
saturated DMPG-SUVs. The far-ultraviolet CD spectra of the en-
zymes in solution display spectral features characteristic of -helical–
rich proteins, whose helical content is only slightly altered upon 
binding to the negatively charged SUVs (fig. S3A). The thermal sta-
bility of both proteins was investigated by following the ellipticity at 
222 nm upon heating (fig. S3B). Denaturation curves were fitted to 
a two-state model of protein unfolding, providing the melting tem-
perature (Tm) and apparent enthalpy (Happ) change of the transi-
tion (table S1) (31). Both enzymes are more thermally stable in the 
presence of lipids at high concentrations, with PimB (Tm ~ 2.6° to 
3.4°C) being more perturbed than PatA (Tm ~ 1.1° to 1.8°C). The 
unfolding Happ of membrane-bound PatA is larger than that of the 
free enzyme, whereas the unfolding enthalpy of PimB is compara-
tively reduced in the presence of the lipids. This result indicates a dif-
ferent interaction mechanism for each enzyme with lipid membranes. 
The increase in the Tm and the unfolding enthalpy of PatA bound to 
the lipid bilayer suggests an enhancement of both intraprotein and 
protein-lipid interactions that contribute to the stabilization of the 
enzyme’s native state.
To evaluate the impact of the enzymes on the thermotropic phase 
behavior of lipid vesicles, we carried out DSC experiments using 
DMPG-containing large multilamellar vesicles (LUVs). Binding of 
both PimB and PatA to DMPG-LUVs (140-nm size; Materials and 
Methods for details) affects the thermodynamics of the lipids in a 
concentration-dependent manner (fig. S4A and table S2). The en-
zymes broaden the heat capacity profile of the membrane, reducing 
both the calorimetric enthalpy change and the transition coopera-
tivity of the protein-associated membranes. The DSC thermograms 
of the protein-containing samples display two components: The 
narrow peak corresponds to the protein-free LUVs, while the broad-
er one can be attributed to protein-associated membranes. The gel–
to–liquid crystalline phase transition temperature of the narrow peak 
remains virtually unperturbed of protein concentration, whereas the 
broad peak is shifted to higher temperatures and becomes more 
enthalpic with the addition of increasing enzyme concentrations. 
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(low enthalpic peak at about 14°C; fig. S4A), suggesting structural 
changes in the polar head group of the lipids (32). The thermo-
grams of the membrane registered after PimB denaturation are 
very different from those recorded before protein melting. Upon 
protein denaturation, the broad, PimB-associated membrane peak 
vanishes, suggesting that PimB is released into solution. In contrast, 
the PatA-associated LUV peak remains, suggesting that upon protein 
denaturation, PatA is still attached to the phospholipids (fig. S4B).
Fig. 2. PatA interaction and insertion with different lipid membrane models. SPR sensograms of increasing concentrations of PatA with captured DOPG-SUVs at 25°C 
(A), DMPG-SUVs at 30°C (C), and M. smegmatis membrane lipid SUVs at 25°C (E); and PimB with captured DOPG-SUVs at 25°C (B), DMPG-SUVs at 30°C (D), and M. smegmatis 
membrane lipid SUVs (F). (G and H) Surface pressure increase () plotted as a function of the initial pressure (0) to determine the critical pressure of PatA and PimB in the 
presence of DOPG and DOPC, respectively. Critical pressure of protein insertion (c) of the three proteins is represented on top-right corner of (G) and (H). The lateral biolog-
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PatA inserts into anionic phospholipid monolayers
The insertion of PatA into phospholipid membranes was evaluated 
using Langmuir films at various initial pressure (0) values. PatA 
was injected underneath DOPG:DOPC (60:40, w/w) (DOPG) and 
DOPC monolayers prepared at the air-water interface, and the inter-
action was quantified by surface pressure measurements. The criti-
cal pressure of insertion (c), determined by the abscissa intercept 
of the surface pressure increase versus 0 plot, indicates the protein 
propensity for membrane insertion. Hence, a larger c indicates a 
higher propensity for protein insertion into monolayers. The lateral 
pressure of biological membranes corresponds to a surface pressure 
of 30 to 35 mN m−1 in the Langmuir monolayers experiments (33). 
Therefore, it is generally accepted that c values between 30 and 
35 mN m−1 strongly suggest insertion of the protein into the lipid 
monolayer (34–36). PatA displayed a c of 31.54 mN m−1 in DOPG 
(R2 = 0.92) phospholipid monolayer and a c of 30.96 mN m−1 (R2 = 
0.89) in DOPC monolayer experiments, supporting the notion that 
the enzyme inserts into both types of phospholipid monolayers but 
preferably into the DOPG monolayer. PimB showed a c value of 
28.38 mN m−1 (R2 = 0.95) in DOPG experiments and 21.5 mN m−1 
(R2 = 0.85) in DOPC experiments, consistent with a peripheral lo-
calization, while the soluble bovine serum albumin (BSA) has a c 
value of 20.18 mN m−1 (R2 = 0.99) and 20.91 mN m−1 (R2 = 0.99) in 
DOPG and DOPC experiments, respectively (Fig. 2, G and H).
PatA insertion modifies the dynamics of anionic 
phospholipid bilayers
We applied ESR spectroscopy to probe the effects of protein binding 
on the ordering and dynamics of phospholipid bilayer membranes. 
Spin-labeling ESR is a powerful spectroscopic tool to study changes in 
the structural dynamics of lipids and proteins during protein-lipid 
interactions (37–39). ESR experiments were performed with DMPG- 
SUVs at different lipid-to-protein (L/P) molar ratios, using nitroxide 
labels attached to both the head group region [1,2-dipalmitoyl-sn- 
glycero-3-phospho(tempo)choline (DPPTC)] and the acyl chain region 
(5-PCSL and 14-PCSL) of phosphatidylcholines, allowing to mon-
itor protein-induced changes from the membrane surface (DPPTC) 
to the hydrophobic core of the phospholipid bilayer (5-PCSL and 
14-PCSL) (39).
In the DMPG-SUVs ripple gel phase, remarkable line broadening 
was obtained in the presence of the enzymes for all spin labels (Fig. 3, 
A and C). The observed spectral changes suggest that both PimB 
and PatA reduce lipid mobility and increase the membrane packing 
from the lipid-water interface down to the center of the bilayer. In 
particular, the effective order parameter (Szz) of the 5-PCSL spectra 
(see Materials and Methods) increased by 0.06 and 0.09 in the pres-
ence of PatA and PimB, respectively, at an L/P of 200. Moreover, 
PimB is slightly more effective than PatA at reducing the parameter 
h+1/h0, the ratio between the intensity of the low (h+1) and the cen-
tral (h0) field lines of the 14-PCSL spectra (14.6% versus 12.8%, re-
spectively). The lower the h+1/h0, the more packed or less dynamic 
are the spin probes. These results indicate that the binding of PimB 
to DMPG-SUVs makes the gel phase of the protein-lipid system 
more packed/ordered than the PatA/lipid gel phase. In contrast, the 
head group region is more perturbed by PatA than by PimB (Fig. 3A 
and fig. S5B), suggesting different membrane interaction mecha-
nisms for both enzymes. The protein-induced perturbation of the 
ordering and mobility of the head group region and acyl chains in 
the DMPG gel phase may explain the reduced intermolecular coop-
erativity of the lipid phase transition and the effect of the proteins 
on the lipid pretransition, as seen by DSC. However, the most in-
teresting results were obtained in the fluid phase of DMPG-SUVs. 
Fig. 3. PatA changes the structural dynamics of DMPG lipid bilayers. ESR spectra of DPPTC (A and D), 5-PCSL (D and E), and 14-PCSL (C and F) obtained in the gel phase 
(20°C; A to C) and in the fluid phase (30°C; D to F) of DMPG-SUVs in the absence (black lines) and presence of PatA (spectra on the top of each panel) and PimB (spectra on 
the bottom of each panel) at different L/P molar ratios (colored lines). The arrow in (D) indicates a sharp spectral component. The spectra were normalized by the number 
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PatA substantially increased the lipid ordering and decreased the 
lipid mobility (fluidity) of the acyl chain region of the membrane, 
as evidenced by the broadening of the 5-PCSL and 14-PCSL spectra 
(Fig. 3, E and F). The Szz values for the 5-PCSL increased by 0.07 in 
the presence of PatA at an L/P of 200, while the parameter h+1/h0 
for the 14-PCSL was reduced by about 9% at an L/P of 150. In con-
trast, the effect of PimB on the acyl chain region of the bilayer was 
practically negligible, yielding virtually similar ESR spectra for the 
5-PCSL and 14-PCSL (Fig. 3, E and F).
On the other hand, binding of PatA and PimB to DMPG-SUVs in 
the fluid phase yields opposing effects in the head group region, de-
spite both proteins decreasing the h+1/h0 values for the DPPTC (fig. 
S5B). While PatA induces extensive line narrowing in a concentration- 
dependent manner, PimB slightly broadens the DPPTC ESR spectra 
(Fig. 3D). The interaction of PatA with the DMPG-SUV in the fluid 
phase gives rise to a second, narrow component in the DPPTC spec-
tra (arrow in Fig. 3D) superimposed with a broad signal. The relative 
population of the narrow component grows in intensity with the 
addition of PatA (arrow in the fig. S5A). To quantify the order pa-
rameter (S0), the rotational diffusion rate (R⊥), rotational correlation 
times (), and the populations of both spectral components, non-
linear least-squares (NLLS) simulations of the DPPTC ESR spectra 
were performed, and the best-fit parameters are summarized in the 
table S3.
NLLS spectral fitting successfully reproduced the two-component 
feature of the DPPTC ESR signal from the PatA/DMPG system (Fig. 4C) 
along with the typical one-component spectra of DPPTC in the protein- 
free (Fig. 4A) and PimB-decorated membranes (Fig. 4B). Spectral 
simulations indicate that PatA insertion into DMPG-SUVs induces 
a much less packed (lower S0) and more dynamic lipid head group 
than the protein-free membranes, as indicated by the dependence of 
S0 and R⊥ of the DPPTC broad component as a function of PatA con-
centration (Fig. 4D). In contrast, the peripheral interaction of PimB 
with DMPG-SUVs in the fluid phase only slightly increases the or-
dering and decreases the rotational diffusion of the head group re-
gion (Fig. 4D).
Moreover, the sharp component is characterized by much faster 
motion ( of about 0.32 to 0.41 ns) and lower packing (S0 ~ 0.13) 
than those obtained from the broad signals ( of 1.08 to 2.24 ns and 
S0 ~ 0.16 to 0.48). The relative population of the sharp component 
roughly linearly increases with PatA addition (from 0.9% at L/P = 
1000 to about 22.5% at L/P = 100; table S3), suggesting an additive 
effect. The appearance of sharp signals in the ESR spectra of nitroxide- 
labeled lipids upon protein-membrane interactions has been at-
tributed to defect formation in the lipid bilayer (40). In particular, a 
defect-like structure in the membrane hydrophobic core has been ob-
served for the Escherichia coli dihydroorotate dehydrogenase. The 
authors concluded that the insertion of the enzyme N-terminal helices 
into the lipid bilayer acts as a spacer of the lipid acyl chains, gener-
ating sharp spectral components in the ESR spectra (41). Therefore, 
the emergence of a narrow component in the DPPTC spectra in the 
PatA-embedded DMPG-SUV is consistent with the formation of 
local defects in the head group region likely due to the insertion of the 
PatA N-terminal  helices into the lipid bilayer.
Our ESR results are summarized as follows. In the gel phase, 
PatA and PimB remarkably alter the ordering and mobility of the 
DMPG-SUVs lipids, exerting a differential effect in the head group 
and in the acyl chain regions. In the fluid phase, (i) the enzymes pro-
mote opposing effects in the structural dynamics of the DMPC/DMPG 
head group region; (ii) the effect of PimB is restricted to the bilayer 
surface, consistent with a peripheral membrane attachment mech-
anism; and (iii) PatA increases the packing of the acyl chains and 
Fig. 4. PatA promotes extensive disordering of the DMPG head group region. NLLS simulations of the DPPTC ESR spectra acquired at 30°C in the absence (A) and 
presence of 0.5 mole percent (mol %) (L/P = 200) of PimB (B) or PatA (C). Experimental spectra are shown in black, the best fit in red, and the residuals in gray. The spectra 
in (A) and (B) are typical one-component spectra, whereas the spectrum in (C) was simulated with two spectral components. The sharp component (purple) of the 
spectrum in (C) accounts for 9% of the total spin population. Spectral width is 100 Gauss. (D) Dependence of the order parameter (top) and the rotational diffusion rate 
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enhances defects in the membrane head group region, supporting a 
model of PatA insertion into the bilayer hydrophobic core.
A two-helix motif positions PatA active site for catalysis 
within the membrane bilayer
Analysis of the amino acid sequence of PatA revealed the lack of a 
signal peptide or hydrophobic transmembrane segments, suggesting 
that PatA associates with only one side of the lipid bilayer, a feature 
typical of peripheral or monotopic integral membrane proteins (42). 
We have recently solved crystal structures of PatA from M. smegmatis 
mc2155 (MSMEG_2934; 304 residues) in complex with (i) its natu-
rally occurring palmitoyl donor (PatA-C16) (43), (ii) a nonhydro-
lyzable palmitoyl-CoA analog (PatA-S-C16-CoA) (43), and (iii) the 
6-O-palmitoyl--d-mannopyranoside product (PatA-ManC16) (44). 
The high quality of the electron density maps allowed the trace of 
residues ca. 40 to 303. The structures revealed an / architecture, 
with the palmitoyl residue deeply buried into a hydrophobic pocket 
that runs perpendicular to a long groove where the active site is lo-
cated (Fig. 5A). The 4-phosphopantetheinate moiety of S-C16-CoA 
is located at the entrance of the main groove, in close contact with a 
highly conserved region flanked by the 2-8 (residues 149 to 153), 
3-9 (residues 174 to 180) and 4-5 (residues 199 to 207) loops, 
and two  helices, 9 (residues 181 to 190) and 10 (residues 221 to 
230). The adenosine 3′,5′-diphosphate (3′,5′-ADP) moiety of the 
ligand sticks out from the core domain of the enzyme and is exposed 
to the bulk solvent (43, 44). In contrast, the Manp ring of ManC16 
is located within a cavity located at the end of the main groove and 
comprising helices 4 and 8 and the connecting loops 1-7 (res-
idues 83 to 90), 2-8 (residues 148 to 154), and 11-12 (residues 
282 to 291; Fig. 5B). Specifically, the Manp ring is mainly stabilized 
by van der Waals interactions with the side chains of four aromatic 
residues Tyr83, Trp84, Trp130, and Phe160. In addition, the O6 atom of 
the Manp ring makes a hydrogen bond with the NE2 atom of the 
imidazole moiety in His126, whereas the O2 atom makes a weak hy-
drogen bond with the NH2 atom of Arg164 (Fig. 5B). It is worth noting 
that both PIM2 acyl chains are essential for PatA enzymatic activity, 
supporting the notion that they play a prominent structural role in 
the arrangement of the sugar moiety/moieties into the catalytic center. 
The first 40 residues of PatA predict the formation of two amphipathic 
helices, 1 and 2 (Fig. 5, A to D). However, the positioning and in-
volvement of these helices in the binding of the PIM1/PIM2 lipid 
acceptors and membrane interaction remain unknown.
The electrostatic potential of the PatA surface revealed a clear 
solvent-exposed area bordering the main groove containing sev-
eral hydrophobic and aromatic residues interspersed with positively 
charged residues (Fig. 5, E and F). Specifically, this region comprises 
the amphipathic helices 3, 4, and 8, and the connecting loop 2-8 
(residues 148 to 154; Fig. 5C). In contrast, the opposite side of PatA 
exhibits a negatively charged surface, which would generate signif-
icant electrostatic repulsion with the anionic phospholipid bilayer. 
Therefore, the polar character of PatA seems to determine the cor-
rect orientation of the enzyme into the membrane (Fig. 5C). To es-
tablish the preferred binding orientation of full-length PatA within 
the phospholipid bilayer and the involvement of the helices 1 and 
2, in PIM1/PIM2 acceptor and membrane association, we modeled 
helices 1, 2, and partially 3 and carried out 0.5-s MD simula-
tions of PatA embedded in one leaflet of the bilayer (see Materials and 
Methods). To this end, we used the coordinates of PatA contain-
ing (i) the C16-CoA donor molecule based on the PatA-S-C16-CoA 
crystal structure and (ii) the PIM2 glycolipid molecule docked into 
the acceptor binding site based on the PatA-ManC16 structure (Fig. 5, 
C and D). The calculations show that the complex is stable in the 
membrane throughout the simulation time and that helices 1 and 
2 interact with the polar fragments of the inner layer via several hy-
drogen bonds (fig. S6A). In addition, the inositol moiety, one of the 
mannose, and the phosphate group of the PIM2 glycolipid are in-
volved in hydrogen bonds (fig. S6B) and hydrophobic contacts with 
the protein.
The ruler mechanism for acyl chains recognition
In the crystal structures previously reported, we observed that PatA 
has a hydrophobic cavity where the acyl chain of the palmitoyl-CoA 
(C16) donor is deeply buried (Fig. 5, A and B). The length of this 
cavity might determine the ability of the enzyme to recognize a cer-
tain number of carbon atoms in the acyl chain of the acyl-CoA sub-
strates. To this end, we measured the specific activity of PatA against 
acyl-CoA derivatives with different lengths of the acyl chain, in-
cluding C2-CoA, C8-CoA, C12-CoA, C14-CoA, C16-CoA, C18-CoA, 
and C20-CoA, by a spectrophotometric assay using 5,5′-dithio-bis- 
(2-nitrobenzoic acid) (DTNB; Fig. 6A). The assay measures the ab-
sorption of the released TNB+2 produced by reaction between DTNB 
and the CoA released when PatA catalyzes the transfer of the acyl 
chain from an acyl-CoA derivative to PIM2. All reactions were per-
formed in the presence of an artificial membrane model DOPC- 
SUVs, which is required for the PatA reaction (44). The assays showed 
that the highest activity corresponds to C14-CoA, followed by the 
C12-CoA and C16-CoA derivatives; the last was previously described 
as the preferred acyl-CoA donor substrate of the enzyme (16, 45). 
The formation of the reaction products was detected and confirmed 
by mass spectrometry (MS) in all the reactions (fig. S7 and table S4). 
The increase or decrease in the acyl chain length in the CoA sub-
strate derivatives, compared to C14-CoA, resulted in a gradual re-
duction of enzymatic activity, with almost no activity with C2-CoA 
and C20-CoA. The activity measurements showed a clear Gaussian- 
like curve profile, strongly supporting the notion that PatA can rec-
ognize subtle differences in acyl chain lengths in CoA derivatives. 
The C14-CoA derivative unexpectedly showed the highest specific 
activity compared to C16-CoA. This could be due to a different bind-
ing mode between the enzyme and the C14-CoA, with respect to the 
natural substrate C16-CoA. With this in mind, we studied the im-
pact of acyl chain length on the binding of different acyl-CoA de-
rivatives to PatA, using ITC. To this end, we chemically synthesized 
the nonhydrolyzable ether substrates S-lauroyl-CoA (S-C12-CoA), 
S-stearoyl-CoA (S-C18-CoA), and S-arachidoyl-CoA (S-C20-CoA). 
Specifically, the nonhydrolyzable ether substrates were obtained by 
conjugation of CoA-SH with the corresponding alkyl iodide follow-
ing described protocols (46). In addition, S-tetradecyl-CoA (S-C14-
CoA) and S-hexadecyl-CoA (S-C16-CoA) were purchased in Avanti 
Polar Lipids. We detected binding exclusively with S-C16-CoA (KD = 
7.18 ± 1.17 M), the derivative that was previously described as 
the preferred donor substrate of the enzyme (Fig. 6B and fig. S8) 
(47). Together, the experimental data support a fatty acid ruler as the 
mechanism by which PatA specifically recognizes the donor acyl 
chain of CoA.
To better understand the recognition mechanism of the donor 
substrate, we attempted to obtain the cocrystal structure of PatA in 
complex with the nonhydrolyzable substrates S-C12-CoA, S-C14-
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Fig. 5. PatA overall structure and membrane association. (A and B) Two views of the x-ray crystal structures of PatA in complex with nonhydrolyzable S-C16-CoA 
[Protein Data Bank (PDB) code 5F34]. The Man-C16 product was placed by superposition of the crystal structure of PatA in complex with the Man-C16 product (PDB code 5OCE). 
S-C16-CoA is shown in blue, Man-C16 product in green, PatA’s -strands in yellow, and  helices in orange. The modeled 1, 2, and partial 3 are highlighted in purple. 
(C) Model of PatA and membrane interaction result from MD simulations. The membrane bilayer apolar face is shown in light blue, phospholipids external heads are shown 
in red and orange, the PatA  strands are shown in yellow, and  helices are shown in orange. The reaction product, Ac1PIM2, is modeled in purple. (D) A closer snapshot 
derived from 0.5-s MD simulations superimposed with the nonhydrolyzable S-C16 CoA (in blue). (E and F) Two views of Coulombic surface representation of PatA and the 
membrane interaction model obtained by MD calculations. The polar character of the enzyme is shown in three colors; negatively charged patches in red (−10 kcal mol−1), 
hydrophobic zones in white (0 kcal mol−1), and positively charged residues in blue (10 kcal mol−1). The modeled Ac1PIM2 reaction product is colored in green. The palmitate 
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crystals for PatA in the presence of the S-C12-CoA derivative and 
solved the structure at 3.67-Å resolution in the space group P21 
(Fig. 6D, fig. S9, and table S5). Structural comparison of this new 
crystal structure with the previously reported PatA-S-C16-CoA com-
plex [Protein Data Bank (PDB) code 5F34] (43) revealed that the 
overall protein structure is essentially preserved [root mean square 
deviation (r.m.s.d.) of 0.36 Å for 245 residues; Fig. 6, C and D]. We 
could not find clear electron density to model the S-C12-CoA sub-
strate in the hydrophobic cavity. It is worth noting that C16 was 
present in the hydrophobic cavity in all reported crystal structures of 
PatA (PDB codes 5OCE, 5F2Z, 5F2T, and 5F34). Unexpectedly, the 
hydrophobic cavity maintains its conformation although it is empty. 
These data suggest that the S-C12-CoA derivative can access both 
the main grove and the hydrophobic cavity and displaces the palmitic 
acid coming from the purification (43). However, since it displays a 
short acyl chain, the S-C12-CoA is released from the active site, as it 
is not sufficiently stabilized.
DISCUSSION
Acyltransferases play a central role in the biosynthesis of bacterial 
phospholipids and glycolipids by catalyzing the transfer of activated 
acyl chains to acceptor molecules of different chemical structure and 
complexity. To this end, fatty acids are usually activated for subse-
quent reactions by esterification of their carboxyl groups with the thiol 
of CoA or ACP, resulting in acyl-thioesters (4). Similar to many other 
membrane acyltransferases, PatA catalyzes a reaction between sub-
strates of completely different nature: (i) the PIM2 glycolipid, which 
is deeply anchored in the mycobacterial IM, and (ii) water soluble 
palmitoyl-CoA. How does the active site of PatA access these two 
chemically different substrates? Our experimental data support a 
model in which the reaction mediated by PatA occurs at the lipid- 
water (mycobacterial IM–cytosol) interface. PatA is permanently at-
tached to the lipid bilayer. This interaction is mainly mediated by the 
insertion of N-terminal helices 1 and 2 into anionic lipid bilayers 
(Fig. 5, C and D). In addition, PatA displays several hydrophobic 
Fig. 6. Acyl chain length recognition activity and binding experiments. (A) PatA-specific hydrolytic activity measured by spectrophotometric DTNB assay with differ-
ent acyl-CoA derivatives (C2-CoA, C8-CoA, C12-CoA, C14-CoA, C16-CoA, C18-CoA, and C20-CoA) in the presence of DOPC-SUVs as an artificial membrane model. The ac-
tivity results of PatA for each compound are plotted in reference to the most active one, the C14-CoA derivative. (B) ITC raw and integrated data for the binding interaction 
of PatA and nonhydrolyzable C16-CoA derivative. The experimental points are represented as filled squares, and the best fit of these points to a one-site binding model 
is represented as a solid curve. (C) The hydrophobic pocket surface shape of PatA crystal structure in complex with palmitate (in green) (PDB code 5F2Z). (D) The empty 
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patches interspersed with clusters of positively charged residues ad-
jacent to the main groove that contain the catalytic site. These hydro-
phobic and negatively charge residues certainly maintain and stabilize 
PatA into the bilayer through electrostatics and London dispersion 
forces with other bilayer components. In addition, the enzyme dis-
plays a negatively charged region at the opposite side of the enzyme, 
oriented toward the cytosol. Therefore, the polar character of PatA 
also contributes to determine the correct orientation of the enzyme 
into the membrane (Fig. 5, E and F) (43, 44). In that context, PatA rec-
ognizes the polar head group of the PIM1/PIM2 glycolipid acceptor 
molecule in a region of the major groove mainly flanked by helix 4. 
The fatty acid chains of PIM1/PIM2 are essential for the activity of the 
enzyme, contributing to the mannose/s and inositol residues into 
the binding site (44). Notably, PatA can sequester the acyl chain of the 
acyl-CoA donor substrate from the cytosol and incorporate it into a 
hydrophobic tunnel that extends entirely through the core of the en-
zyme. The adenosine 3′,5′-ADP moiety of the acyl-CoA protrudes 
away from the groove and is exposed to bulk solvent, as observed in 
other acyl-CoA modifying enzymes. Thus, PatA transfers the C16 
acyl group to PIM1/PIM2 in a two-step reaction mechanism in which 
Fig. 7. Model of membrane association mechanism of PatA. (A to C) The N-terminal helices 1 and 2 and the polarity of PatA determines the right orientation of the 
enzyme on the membrane. PIM2 is anchored into the inner leaflet of the mycobacterial IM. C16-CoA is localized in the cytosol. (B to D) PatA sequesters the acyl chain of 
the acyl-CoA donor substrate from the cytosol and incorporates it into a hydrophobic tunnel that extends entirely through the core of the enzyme. In this orientation, the 
polar head of PIM2 enters into a cavity located in the major groove to react with the acyl-CoA, at the protein-membrane interphase. The Ac1PIM2 product is formed and 
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His126 acts as a general base to deprotonate the hydroxyl group of a 
mannose ring in PIM1/PIM2, facilitating nucleophilic attack on the 
thioester of the acyl-CoA. The reaction is assisted by Glu200, which 
modulates the pKa of the central histidine as a general base or acid 
during the catalytic cycle, similar to the charge-relay system of 
serine proteases.
Brennan and Ballou (47) were the first to study the fatty acid donor 
specificity of PatA, in the context of the acylation of PIMs. By using 
radioactivity experiments, they showed that palmitic (C16), myristic 
(C14), and oleic (C18, cis-9) acid could be incorporated into phos-
pholipids isolated from Mycobacterium phlei. More recently, differ-
ent acyl-forms of PIM2, and among them, Ac1PIM2, the product of 
the reaction catalyzed by PatA, were isolated from M. bovis BCG and 
characterized (45). Matrix-assisted laser desorption/ionization tan-
dem MS analysis have notably revealed that the Manp is selectively 
acylated by a C16 acyl appendage (48). Our hydrolytic experiments, 
DNTB assays and direct liquid chromatography (LC)–MS detection, 
showed that PatA could transfer all the acyl-CoA derivatives used 
(C2, C8, C12, C14, C16, C18, and C20) to PIM2. Although the enzyme 
showed the highest activity using C14-CoA, and not C16-CoA, we 
only detected binding of PatA to the nonhydrolyzable S-C16-CoA 
derivative by ITC, supporting the notion that C16-CoA is the natural 
donor substrate of PatA (45) The high activity of PatA in the presence 
of C14-CoA, a non-natural substrate of the enzyme, and the low 
binding affinity of the enzyme to the nonhydrolyzable homolog de-
rivative with the same chain length might be explained by an easier 
release of the C14 product facilitating reaction turnover.
Our activity measurements showed a clear Gaussian-type curve 
profile of PatA activity against acyl-CoA derivatives of different 
lengths (Fig. 6A). These data strongly support the notion that PatA 
can recognize acyl-CoA derivatives differently, based on acyl chain 
length. Specifically, the hydrophobic tunnel acts as a ruler that mea-
sures the length of the acyl chains and therefore determines the spe-
cific recognition of the substrate. The acyltransferase LpxM from 
Acinetobacter baumannii (AbLpxM), a structural homolog of PatA 
(49) (PDB codes 5KN7 and 5KNK; Z score of 26.7; r.m.s.d. value of 
2.6 Å for 243 aligned residues), transfers C12 length acyl chains in-
stead other acyl chains length tested (C10, C14, and C16). We showed 
that the C16-CoA derivative was too long to fit in the hydrophobic 
groove of AbLpxM, which is much shorter than the one present in 
PatA (44). This hydrocarbon ruler mechanism has evolved in other 
enzymes that need to distinguish between different fatty acyl chain 
lengths in CoA and ACP derivatives, including (i) the pimeloyl-CoA 
synthetase (BioW) from Bacillus subtilis involved in the biosynthesis 
of biotin; (ii) the acyltransferase LpxA from E. coli; and (iii) the outer 
membrane acyltransferase PagP from E. coli, (50, 51), which are both 
involved in the biosynthesis of Lipid A; (iv) the 1-acyl-glycerol-3- 
phosphate acyltransferase from Thermotoga maritime (TmPlsC), in-
volved in membrane phospholipids biosynthesis (52); and (v) the 
eukaryotic S-acyltransferase (human DHHC20 and zebrafish DHHC15) 
that catalyzes protein palmitoylation (53). Notably, acyl chain length 
specificity could be modified by modulating the length correspond-
ing acyl chain recognition grooves using point mutations (51–53). 
This ruler mechanism is a general substrate recognition strategy, wide-
spread in enzymes that catalyze several reaction types, including sol-
uble and membrane proteins (51, 54) such as glycosyltransferases, 
amylomaltases, ribonucleases, and aminopeptidases (51, 54–57).
Evolution has led enzymes to acquire exquisite molecular mech-
anisms to access lipophilic substrates located in membranes and 
then catalyze their chemical reaction with polar, water-soluble com-
pounds (5). When enzymes have an active site embedded in the mem-
brane, the hydrophobic substrate laterally diffuses from the plane of 
the membrane and into the transmembrane region through hydro-
philic channels. These channels are present in enzymes with differ-
ent overall folds. When enzymes show an active site not embedded 
in a membrane, the hydrophobic substrate is extracted by a desorp-
tion mechanism from the membrane and binds to a channel or cav-
ity located within the main core of the protein. Last, some enzymes 
have the active site located exactly at the membrane surface, where 
both hydrophobic and hydrophilic substrates may stay in their origi-
nal environment with the reaction occurring at the membrane-water 
interface (5). PatA follows a different mechanism. The enzyme dis-
plays an active site located in a major groove facing the membrane 
surface. PatA sequesters the C16 acyl group from the soluble C16-
CoA and incorporates it into a hydrophobic tunnel, deeply buried 
in the core of the enzyme. The polar head of PIM1/PIM2 enters into 
a cavity located in the major groove, whereas the fatty acid chains 
of the glycolipid remain attached or partially sequestered from the 
membrane (Fig. 7).
In summary, we showed that the interaction and insertion of the 
acyltransferase PatA within anionic lipid bilayers are typical of an 
integral membrane protein. This mode of interaction, as well as the 
architecture of the substrates binding sites and the catalytic site, de-
termines the ability of the enzyme to facilitate the reaction of mole-
cules with different chemical characteristics. Moreover, our enzymatic 
and binding experiments showed that PatA can transfer acyl groups 
from acyl-CoAs of different chain lengths via a hydrocarbon ruler 
mechanism. Many structural, chemical, and mechanistic aspects of 
this type of membrane enzymology remain intriguing and major 
challenge. From a drug discovery perspective, we hypothesize that 
the presence of clear and deep pockets might facilitate the discovery 
of potent inhibitors against the enzyme.
MATERIALS AND METHODS
Materials
The phospholipids DOPC, DOPG, DMPC, and DMPG; the spin 
labels 1-palmitoyl-2-stearoyl(n-doxyl)-sn-glycero-3-phosphocholine 
(n-PCSL; where n = 5 and 16) and DPPTC; the CoA derivatives, 
12:0 CoA (C12-CoA), 14:0 CoA (C14-CoA), 16:0 CoA (C16-CoA), 
18:0 CoA (C18-CoA), and 20:0 CoA (C20-CoA) ammonium salts; and the 
nonhydrolyzable CoA derivatives 16:0 ether CoA and 14:0 ether CoA 
ammonium salts, were purchased from Avanti Polar Lipids Inc. 
(Alabaster, AL). The 02:0 acetyl-CoA lithium salt (C2-CoA) and 08:0 
octanoyl-CoA ammonium salt (C8-CoA) were purchased from Sigma- 
Aldrich (Missouri, USA). All reagents were used without further purifi-
cation. PIM2 was chemical synthetized as previously described (44).
Expression and purification of PatA from  
M. smegmatis mc2155
The full length patA gene from M. smegmatis mc2155 (MSMEG_2934; 
UniProt code A0QWG5) was inserted into the pJAM3 plasmid, using 
the Nde I and Xho I sites (pJAM3-patA). The pJAM3 plasmid is a 
derivative of pJAM2 plasmid, where an Nde I site was generated in 
the multiple cloning site. M. smegmatis mc2155 cells, transformed 
with pJAM3-patA, were grown in MM63 medium [15 mM (NH4)2SO4 
and 100 mM KH2PO4] supplemented with 0.5 mM MgSO4, 0.025% (v/v) 
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supplemented with kanamycin (20 g ml−1; fig. S1) (44). When the 
culture reached optical density at 600 nm (OD600) = 0.6, the expres-
sion of PatA was induced by adding 0.2% acetamide. After 30 hours 
at 37°C, cells were harvested at 5000g for 20 min at 4°C and resus-
pended in 20 mM tris-HCl (pH 7.5) containing protease inhibitors 
(Complete EDTA-free, Roche) and culture of benzonase (0.5 l liter−1; 
Sigma-Aldrich). Cells were disrupted by sonication in 36 cycles of 
10-s pulses, with 60-s cooling intervals between the pulses, and 60% 
of amplitude. To solubilize the protein from the mycobacterial mem-
brane, we added a final concentration of 2 mM CHAPS, 300 mM 
NaCl, and 10% glycerol, to the previous disrupted cells mixture. The 
suspension was gently stirred during 1 hour at 4°C and centrifuged at 
59,000g for 30 min at 4°C. The supernatant was filtered by 0.22-m 
pore-size Merck Millipore Durapore polyvinylidene difluoride (PVDF) 
membrane filters and applied to a Co2+ Talon Resin (GE Healthcare; 
ratio 1 ml of resin:1000 ml of culture volume) equilibrated in 20 mM 
tris-HCl (pH 7.5), 300 mM NaCl, and 10% glycerol and incubated 
with gently stirring on rotator for 1 hour at 4°C. The resin was then 
transferred to an empty column and washed with 25 column volumes 
(CV) of 20 mM tris-HCl (pH 7.5), 300 mM NaCl, 10 mM imidazol, 
and 10% glycerol. The proteins were then eluted by gravity flow with 
a step gradient of 20, 50, 75, 100, 200, 300, and 500 mM imidazole, in 
20 mM tris-HCl (pH 7.5), 300 mM NaCl, and 10% glycerol, three CV 
each. The fractions of interest were pooled and dialyzed against 5 liters 
of 50 mM tris-HCl (pH 7.5), 150 mM NaCl, and 10% glycerol over-
night at 4°C. The protein was loaded onto a Superdex 200 10/300 GL 
(GE Healthcare) equilibrated in the 20 mM tris-HCl (pH 7.5) and 
150 mM NaCl. The resulting preparation displayed a single-protein 
band when analyzed by SDS–polyacrylamide gel electrophoresis 
(PAGE). The purified full-length PatA was stored at −80°C. We ob-
tained 1.6 mg of purified PatA per liter of culture.
Expression and purification of PimB from  
M. smegmatis mc2155
E. coli BL21(DE3) cells transformed with pET29a-pimB were grown 
in 2xYT medium supplemented with kanamycin (50 g ml−1) at 37°C 
(29). When the culture reached OD600 = 0.6, PimB expression was 
induced by adding 1.0 mM isopropyl--d-thiogalactopyranoside. 
After 20 hours at 18°C, cells were harvested at 5000g for 20 min at 
4°C and resuspended in 50 mM tris-HCl (pH 8.0), 500 mM NaCl, 
10 mM imidazol, and 25% glycerol containing protease inhibitors 
(cOmplete EDTA-free, Roche) and culture of benzonase (0.5 l liter−1; 
Sigma-Aldrich). Cells were then disrupted by sonication in 12 cycles 
of 10-s pulses, with 60-s cooling intervals between the pulses, and 
60% of amplitude, and the suspension was centrifuged for 30 min at 
59,000g at 18°C. The supernatant was filtered by 0.22-m pore-size 
Merck Millipore Durapore PVDF membrane filters and subjected to 
Ni2+-affinity chromatography using a HisTrap Chelating column (1 ml; 
GE Healthcare) equilibrated in 50 mM tris-HCl (pH 8.0), 500 mM 
NaCl, 10 mM imidazole, and 25% glycerol. The elution was performed 
with a linear gradient of 20 to 250 mM imidazole at 1 ml min−1. The 
fractions of interest were pooled and dialyzed overnight at 4°C against 
50 mM tris-HCl (pH 7.5), 350 mM NaCl, and 25% glycerol. The pro-
tein was loaded onto a Superdex 200 10/300 GL (GE Healthcare) 
equilibrated in 50 mM tris-HCl (pH 7.5), 350 mM NaCl, and 25% 
glycerol. The resulting preparation displayed a single protein band 
when analyzed by SDS-PAGE. The purified PimB was aliquoted and 
stored at −80°C. We obtained 6.25 mg of purified PimB per liter of 
growth culture.
Isolation of native lipids from M. smegmatis mc2155
M. smegmatis mc2155 strain was cultured in 200 ml of Middlebrook 
7H9 supplemented with 10% (v/v) OADC (oleic acid, albumin, 
dextrose and catalase) enrichment medium [NaCl (8.8 g liter−1), 
albumin bovine fraction V (Amresco), dextrose (20 g liter−1), 0.05% 
(v/v) of 1% stock solution of oleic acid, catalase (40 mg liter−1), and 
0.5% (v/v) glycerol] for 3 days at 37°C in absence of agitation. 
Bacterial cultures were centrifuged at 5000g for 10 min at 4°C. The 
resulting pellet was washed with 137 mM NaCl, 2.7 mM KCl, 8 mM 
Na2HPO4, and 2 mM KH2PO4 [phosphate-buffered saline (PBS)] at 
4°C. The cells were resuspended in PBS, 250 mM sucrose, and 1 mM 
EDTA, supplemented with protease inhibitors, and disrupted in a 
FastPrep-24 5G bead beater using zirconia beads (0.1 mm zirconia/
silica; BioSpec Products), nine beating cycles of 30 s, with 60-s cool-
ing intervals between the pulses. The lysed cells were centrifuged at 
10,000g for 10 min at 4°C to remove the beads and unbroken cells. 
The supernatant was centrifuged at 100,000g for 1 hour at 4°C. The 
isolated M. smegmatis membranes were resuspended in PBS, 250 mM 
sucrose, 20 mM tris-HCl (pH 7.5), 300 mM NaCl, and 10% glycerol 
and quickly frozen at −80°C.
Liquid-liquid extraction technique was used to purify the mem-
brane’s lipids. To this end, 2.4 ml of CHCl3:CH3OH (2:1) were added 
to 0.3 m of the M. smegmatis mc2155 membranes. The mixture was 
vigorously mixed, and the organic and aqueous phases were separated 
because of the solvents immiscibility at 4°C. The organic phase was 
washed with water and 2 M NaCl, and the polar phase was washed with 
CHCl3:CH3OH (2:1) twice. All the saved organic phases were collected 
in a tube, dried under a N2 flow, and centrifuged for 1 hour under 
vacuum in a RVC 2-25 CD plus concentrator at 37°C to remove traces 
of organic solvents. Two milligrams of dry lipid film was obtained.
Preparation of SUVs
For SPR measurements, a dry lipidic film [DOPC, DOPG:DOPC 
(60:40, w/w), or M. smegmatis mc2155 membrane lipids] was pre-
pared from a CHCl3:CH3OH (2:1) solution by removing the sol-
vent under a stream of N2 and ultracentrifuged under vacuum for 
1  hour to remove traces of organic solvent. SUVs of each lipid 
(DOPC films to create DOPC-SUVs, DOPG:DOPC mixture film to 
create DOPG-SUVs, and M. smegmatis mc2155 membrane lipids films 
to create M. smegmatis mc2155-SUVs) were prepared by dispersion 
of the lipids 20 mM tris-HCl (pH 7.5) and 150 mM NaCl by vigor-
ous vortexing and following sonication at 4°C with a probe microtip 
sonicator [MSE Soniprep 150 (MSE, UK)] of two cycles of 5 min 
(5-s on and off cycles) at 100-m amplitude and a break of 5 min in 
between cycles.
For CD, DSC, and ESR measurements, appropriate amounts of 
phospholipids and nitroxide-labeled lipids [0.5 mol percent (mol %) 
for ESR] dissolved in CHCl3:CH3OH (2:1) were mixed in a round- 
bottom glass tube, dried under a nitrogen stream, and kept under 
vacuum overnight to remove traces of organic solvent. The lipid film 
was hydrated with the appropriate buffer at a temperature ~10°C 
higher than the main phase transition temperature (Tm) of the lipid 
components, and submitted to intense vortexing. Samples were then 
subjected to five freeze-thaw cycles. SUVs were prepared by sonicating 
the resulting multilamellar vesicles (MLVs) on a bath-type sonicator 
at T > Tm + 10°C until the solution became clear. LUVs were obtained 
by subjecting the MLVs to 13 to 17 passes through polycarbonate 
membranes of 100-nm pore size (Nuclepore Corp., Cambridge, 
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distribution of the resultant LUVs and SUVs was confirmed by dy-
namic light scattering using a Zetasizer V (Malvern Instruments).
The preparation of the lipid/protein samples for CD, DSC, and 
ESR was the following. An aliquot of the protein stock solutions was 
added into preformed SUVs or LUVs and gently vortexed for a few 
seconds. The samples were kept equilibrating at a temperature T > Tm 
of the lipids (22°C for DOPG/DOPC or 30°C for DMPG/DMPC) for 
20 min before the experiments.
SPR experiments
SPR experiments were performed in a BIAcore 3000 system (GE 
Healthcare). The running buffer for PatA and PimB experiments was 
50 mM tris-HCl (pH 7.5), 150 mM NaCl, 50 mM tris-HCl (pH 7.5), 
350 mM NaCl, and 25% glycerol, respectively. The chip surfaces were 
first washed with 50 mM NaOH:isopropanol (2:3) and 20 mM CHAPS, 
and then the lipid vesicles were immobilized on the chip’s surface. 
DOPC-SUVs and DMPC-SUVs were immobilized at 5 l min−1 to 
reach a density of 2000 RU (resonance unit) in flow cell 1 as nega-
tive control because we did not observe binding of PatA neither 
PimB to DOPC- SUVs in preliminary experiments. DOPG-SUVs, 
DMPG-SUVs, and M. smegmatis mc2155 lipids SUVs were immobi-
lized at 2 l min−1 to reach the same density in flow cell 2. After lipid 
vesicle immobilization, BSA (1 mg ml−1) was injected at 30 l min−1 to 
fill any possible noncovered chip surface. After baseline stabilization, 
twofold concentration series (from 12 M up to 0.05 M) of 60 l of 
the corresponding protein was injected at 30 l min−1 for 1 min. 
After 5 min of dissociation time, the surface was regenerated with 
50 mM NaOH:isopropanol (2:3) and 20 mM CHAPS between binding 
cycles. Experimental data were corrected for instrumental and bulk 
artifacts by referencing to the flow cell 1, using the BIAevaluation 
4.1 software. The affinity constants (KD) were calculated using a general 
steady-state equilibrium model and the BIAevaluation 4.1 software.
Monolayer studies by Langmuir films
Protein-lipid interactions were studied with the Langmuir film bal-
ance technique using a Kibron microtensiometer (TROUGH SX, 
Kibron Inc. Helsinki, Finland). We have prepared a solution of 1 mM 
of the DOPC- and DOPG-lipids [DOPG:DOPC (60:40, w/w)]. Mono-
molecular films of the indicated lipid were spread on 20 mM tris-HCl 
(pH 7.5) and 150 mM NaCl for PatA and 50 mM tris-HCl (pH 7.5), 
350 mM NaCl, and 25% glycerol for PimB subphases (volume of 
1250 l). The desired lipidic monolayer was created spreading over 
the aqueous subphase of the DOPC or DOPG with a 10-l Hamilton 
syringe inducing different superficial tension values (0) between 15 
and 40 mN m−1. After baseline equilibration, a final concentration of 
100 M protein (PatA, PimB, and BSA) was injected. PimB and BSA 
were used as negative controls. Superficial pressure changes were con-
tinuously recorded as a function of time, and the achieved pressure 
was saved when a plateau was reached (protein). The data were ana-
lyzed with the FilmWareX 3.57 program (Kibron Inc.). The exper-
iment results were plotted following a linear regression between the 
monolayer pressure difference before and after the protein addition 
(max = protein − 0) versus the initial monolayer superficial ten-
sion values (0). The critical pressure of the protein insertion (c) is 
the value where, in the plot, the abscissa axis is crossed.
Continuous wave ESR assays
Lipid and L/P samples transferred to glass capillaries (1.5 mm I.D) 
were placed in a quartz tube. X-band (9.5 GHz) ESR experiments were 
carried out on a Varian E-109 spectrometer using 10-mW microwave 
power and 0.5- to 1.0-G field modulation amplitude. The center field 
was set to 3365 G, and the scan width was 100 to 140 G. The spectra 
were recorded with an acquisition time of 240 s using a time con-
stant of 128 ms. The temperature was controlled by a homemade 
temperature control unit coupled to the spectrometer. ESR spectral 
analysis were carried out as previously described (39) using the Mul-
ticomponent LabVIEW (National Instruments) software developed 
by C. Altenbach (University of California, Los Angeles, CA). The ef-
fective order parameter, Szz, was calculated from the outer (2Amax) and 
inner (2Amin) hyperfine splitting values extracted from the 5-PCSL 
ESR spectra (58).
DSC assays
The effect of PatA and PimB on the thermotropic phase behavior 
of DMPG/DMPC (60:40, mol/mol) liposomes was recorded in a 
VP-DSC MicroCal MicroCalorimeter (Microcal, Northampton, MA, 
USA) using a heating rate of 1.0°C min−1. The samples were firstly 
degassed, loaded into the calorimeter cells, and equilibrated for 10 min 
at 5°C before the measurements. Lipid concentration ranged between 
0.6 and 0.8 mM, whereas the protein-to-lipid molar ratios were 1:400, 
1:200, and 1:100. The lipid vesicles were prepared in 20 mM tris-HCl 
and 150 mM NaCl (pH 7.5). The analyses of the heat capacity pro-
files of the protein-free and protein-bound lipid vesicles were per-
formed using Microcal Origin software (OriginLab Corporation, 
Northampton, MA).
CD analysis
CD experiments were performed on a Jasco J-715 spectropolarimeter 
using a 1-mm path-length quartz cell. The bandwidth and response 
time were set, respectively, to 1 nm and 2 s. The spectra of PatA and 
PimB (3 to 5 M) in the absence and presence of DOPG/DOPC 
(60:40, mol/mol) and DMPG/DMPC (60:40, mol/mol) SUVs were 
recorded at 20°C over the wavelength range of 200 to 270 nm and at 
100 nm min−1. The resultant spectra were averaged over six spectral 
accumulations, each corresponding to an average of six scans, and 
subtracted by the spectra of the protein-free control samples acquired 
under the same conditions. The final spectra were converted to mean 
residue molar ellipticity. Thermal unfolding of PatA and PimB in the 
absence and presence of the lipid vesicles was recorded at 222 nm 
using a heating rate of 1°C min−1 in the 15° to 80°C range. The tem-
perature was controlled using a Peltier thermal device. The data were 
fitted to a two-state equilibrium model between folded and unfolded 
states without heat capacity changes, as described elsewhere (31).
Molecular modeling
First, helices 1, 2, and partially 3 were modeled for PatA using 
the crystal structure of lipid A secondary acyltransferase LpxM as 
a template (PDB code 5KN7) (49) and with PyMOL 2.4 software. 
Subsequently, the PIM2 glycolipid was docked to the PatA-ManC16 
molecule, whose binding pose with the protein was previously revealed 
using x-ray crystallography by our group (PDB code 5OCE) (44).
Bilayers of 1,2-distearoyl-sn-glycero-3-phosphocholine lipid, to-
gether with the modeled complex, H2O molecules, and Cl− to neu-
tralize the system, were constructed using the CHARMM Membrane 
Builder GUI (www.charmm-gui.org) (59) and converted to Lipid17 
PDB format with the charmmlipid2amber.x script included in Amber20 
(60). MD simulations were performed using the ff14SB force field, 
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99 force field force field (ff99SB) (61). Lipid17 force field (62) was 
used to properly simulate the conformational behavior of the lipid 
membrane. Parameters for the PIM2 glycolipid were generated with 
the antechamber module of Amber20 using the general Amber force 
field (63) with partial charges set to fit the electrostatic potential gen-
erated with HF/6-31G(d) by RESP (64). The charges were calculated 
according to the Merz-Singh-Kollman scheme using Gaussian 09 (65). 
The TIP3P water model was used for H2O (66). The full system was 
minimized for 10,000 steps, of which the first 5000 steps used the 
steepest descent method and the remaining steps used the conjugate 
gradient method (67). The system was then heated from 0 to 100 K 
using Langevin dynamics (68) for 5 ps at constant volume, with weak 
restraints on the lipid (force constant, 10 kcal mol−1 Å−2). Following 
this, the volume was allowed to change freely and the temperature 
increased to 300 K with a Langevin collision frequency of  = 1.0 ps−1 
and anisotropic Berendsen regulation (69) (1 atm) with a time con-
stant of 2 ps for 100 ps. The same weak restraint of 10 kcal mol−1 Å−2 
was maintained on the lipid molecules. Constant pressure and con-
stant temperature (NPT) runs were performed using the AMBER 20. 
Bonds involving hydrogen were constrained using the SHAKE al-
gorithm, allowing a 2-fs time step. Structural data were recorded every 
10 ps. PME (particle mesh Ewald) was used to treat all electrostatic 
interactions with a real space cutoff of 10 Å. A long-range analytical 
dispersion correction was applied to the energy and pressure. All 
simulations were performed at constant pressure of 1 atm and constant 
target temperature. Temperature was controlled by the Langevin 
thermostat, with a collision frequency of  = 1.0 ps−1. Pressure was 
regulated by the anisotropic Berendsen method (1 atm) with a pres-
sure relaxation time of 1.0 ps. The system was simulated for 0.5 s.
PatA palmitoyl-CoA hydrolytic activity assay
The specific activity of full-length PatA using different acyl-CoA 
derivatives as acyl donors (C2-CoA, C8-CoA, C12-CoA, C14-CoA, 
C16-CoA, C18-CoA, and C20-CoA) was measured by the spectro-
photometric disulfide DTNB assay, a method described for other 
acyltransferases (43, 44, 70, 71). Specifically, PatA transfers the acyl 
chain from the acyl-CoA compound to PIM2, producing CoA from 
the hydrolysis of the acyl donor. Thus, CoA-SH liberated in the re-
action reacts with DTNB, releasing TNB−2 as a product. TNB−2 ab-
sorbance is measured at 412-nm wavelength in a NanoDrop One 
spectrophotometer (Thermo Fisher Scientific). The reaction contained 
20 mM tris-HCl (pH 7.5), 150 mM NaCl, 1 mM DOPC-SUV, 200 M 
PIM2 mixture, 200 M of the acyl-CoA derivative, 600 M DTNB, 
and 1 M full-length PatA. DOPC-SUV and PIM2 were vortexed to-
gether in 20 mM tris-HCl (pH 8.3), in two cycles of 2 min with a 
2-min time lapse in between. The protein was added after the blank 
was measured. After the reaction started, TNB−2 absorbance was mea-
sured every 3 s for the first 180 s and then every 7 s until 1600 s was 
reached. The absorbance values during the first 60 s were converted 
into the amount of hydrolyzed acyl-CoA derivative per milligram 
of protein in 1 min and compared with the most active one activity 
(C14-CoA in our scenario). All enzymatic activity measurements 
were determined in duplicates.
PatA acyltransferase activity assay
PatA transferase activity was measured by high-resolution LC cou-
pled to MS. A typical reaction contained 20 mM tris-HCl (pH 7.5), 
150 mM NaCl, 1 mM DOPC-SUV, 200 M PIM2 mixture, 200 M 
of the acyl-CoA derivative, 600 M DTNB, and 3.5 M full-length 
PatA. DOPC-SUV and PIM2 are vortexed together in 20 mM tris-HCl 
(pH 8.3), in two cycles of 2 min with a 2-min time lapse in between. 
The reaction was incubated for 3 hours at room temperature. The re-
action was quenched by adding 60% (v/v) final concentration of ace-
tonitrile. In negative control reactions, full-length PatA was added 
after 1 hour and immediately quenched. The quenched samples were 
sonicated for 10 min. To 350 l of sonicated mixture, 350 l of chloro-
form were added, and the solution was incubated for 30 min at room 
temperature under shaking, followed by centrifugation for 5 min at 
4°C and 21,000g for phase separation. One hundred microliters of the 
aqueous phase was dried at −4°C in a rotary vacuum concentrator 
(Labconco). Before LC-MS analysis, samples were resuspended and 
vortexed in 150 l of a CH3OH:H2O (2:1) mixture.
LC-MS measurement
Relative quantification of target compounds was performed using 
an Agilent 1290 LC coupled to an Agilent 6560 quadrupole time-of-
flight (Q-TOF) MS system equipped with a Dual Agilent Jet Stream 
ESI (electrospray ionization) source. The column (Waters ACQUITY 
UPLC BEH C18, 100 × 1 mm, 1.7-m particle size) used in this study 
was maintained at 40°C. The autosampler was kept at 4°C, and the 
injection volume was 10 l. The flow rate was set to 0.12 ml min−1, and 
the mobile phases were consisted of 10 mM ammonium formate in 
60:40 CH3CN:H2O (Eluent A, pH unadjusted) and 10 mM ammoni-
um formate in 90:10 IPN:CH3CN (Eluent B, pH unadjusted). The 
run consisted of a linear gradient from 40 to 99% Eluent B over 6 min, 
followed by an isocratic delivery of 99% Eluent B over 7 min and a 
reequilibration phase on starting conditions with 40% Eluent B for 
7 min. Total run time was 20 min per sample.
MS experiments were performed using ESI in negative mode 
with a capillary voltage of 2000 V and a nozzle voltage of 500 V. The 
deprotonated target molecules were monitored in high-resolution 
mode (slicer position: 5) and Extended Dynamic Range (2 GHz) with 
the following Q-TOF MS conditions: drying gas temperature, 325°C; 
drying gas flow, 10 liters min−1 (nitrogen); nebulizer, 35 psig; sheath 
gas temperature, 350°C; sheath gas flow, 12 liters min−1; fragmentor, 
380 V; and Oct RF Vpp, 750 V. Full-scan spectra were acquired from 
mass/charge ratio (m/z) 50 to 1600 (1 spectrum s−1). External mass 
calibration was performed before measurement of each set of sam-
ples. A reference solution (m/z 112.9855 and m/z 966.0007) was used 
online mass correction during the acquisition. All data were acquired 
with Agilent Mass Hunter LC/MS Data Acquisition (ver B.09.00, 
Build 9.0.9044.0) and analyzed with Agilent Mass Hunter Profinder 
(ver 10.0 SP1, Build 10.0.10142.1). Target compounds were identi-
fied by exact mass (mass error ± 5 parts per minute), isotopic pattern, 
and retention time (± 0.15 min) matching (Batch Targeted Feature 
Extraction; table S4). Semiquantification was based on integrated peak 
area of the deprotonated target compound.
Chemical synthesis of nonhydrolyzable C12-CoA and  
C18-CoA derivatives
To a stirred solution of CoA-SH (1.0 equivalent) in a 1.0 M aqueous 
buffer solution of triethylammonium bicarbonate (1 ml, pH 8.1 to 8.5) 
was added the corresponding alkyl iodide (20 equivalent) at room tem-
perature. The reaction mixture was heated at 50° to 60°C for 16 hours 
before being cooled to room temperature, and then water was added. 
The mixture was extracted with CH2Cl2 to remove the unreacted alkyl 
iodide. The aqueous phase was concentrated, and the residue was pu-
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collected fractions were concentrated in vacuum and lyophilized to 
give the final products as fluffy white solids. See the Supplementary 
Materials for details.
PatA crystallization and data collection
PatA was crystallized by mixing 0.2 l of a protein solution at 
5.22 mg ml−1 in 20 mM tris-HCl (pH 7.5) and 150 mM NaCl in pres-
ence of 1 mM S-C12-CoA derivative, with 0.2 l of 100 mM imidazole/
MES monohydrate (pH 8.5), 60 mM divalent cations mixture (mag-
nesium chloride hexahydrate and calcium chloride dihydrate), and 
50% (w/v) of precipitant mix based on 20% (w/v) PEG 4000 and 
40% (w/v) glycerol (Morpheus protein crystallization screen). The crys-
tals grew in 7 days. The crystals were transferred to a cryo-protectant 
solution containing 30% glycerol and frozen under liquid nitrogen. 
Complete x-ray diffraction datasets for both crystal forms were col-
lected at beamline i03 (Diamond Light Source, Oxfordshire, UK). 
PatA crystallized in the monoclinic space group P21 with four mol-
ecules in the asymmetric unit and diffracted to a maximum resolu-
tion of 3.67 Å (table S5). All datasets were integrated and scaled with 
XDS following standard procedures (72).
PatA structure determination and refinement
Structure determination of PatA was carried out by molecular re-
placement methods implemented in Phaser (73) and the PHENIX 
suite (74) and using the PDB code 5F2Z as a search template. The final 
manual building was performed with Coot (75) and refinement with 
phenix.refine (76). The structure was validated by MolProbity (77). 
Data collection and refinement statistics are presented in table S5. The 
atomic coordinates and structure factors have been deposited with 
the PDB code 7OJT. Molecular graphics and structural analyses 
were performed with the UCSF Chimera package (78).
ITC measurements
ITC essays were performed on a MicroCal PEAQ-ITC (Malvern) at 
25°C. Two hundred microliters of 50 M full-length PatA in 20 mM 
tris-HCl (pH 7.5) and 150 mM NaCl was degasified for 30 min and 
placed into the cell. Forty microliters of 0.716 mM nonhydrolyzable 
acyl-CoA derivatives in 20 mM tris-HCl (pH 7.5) and 150 mM NaCl 
(S-C12-CoA, S-C14-CoA, S-C16-CoA, and S-C18-CoA) were added 
in 13 injections (0.4 l of first injection and 3 l of the rest of them 
with 150-s time lapse between each injection) at 750 rpm. Before data 
analysis was carried out, dilution experiments were performed and 
subtracted (buffer versus buffer, buffer versus full-length PatA, and 
CoA NH derivatives versus buffer) to the raw data. Subtracted ex-
perimental data were fitted, and KD parameters were calculated with 
MicroCal PEAQ-ITC Analysis software (Malvern Instruments Ltd.) 
following One Set of Sites-Single Injection fitting model.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at https://science.org/doi/10.1126/
sciadv.abj4565
View/request a protocol for this paper from Bio-protocol.
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